MedPath

A multicentric, randomized, comparative clinical trial of Armodafinil versus Modafinil in patients with excessive sleepiness associated with shift work sleep disorder (SWSD).

Phase 3
Conditions
Excessive sleepiness associated with shift work sleep disorder
Registration Number
CTRI/2009/091/000617
Lead Sponsor
Emcure Pharmaceuticals Ltd Pune.
Brief Summary

This multicentric, double blind, randomized comparative clinical trial is proposed to evaluate efficacy and safety of Armodafinil versus Modafinil in Indian patients with excessive sleepiness associated with shift work sleep disorder (SWSD). After satisfing exclusion and inclusion criteria, patients will be randomized to receive either Armodafinil or Modafinil. The duration of this study is of 12 weeks and patients will be evaluated at baseline and after 4, 8 and 12 weeks. Efficacy Variables are i)Responder rate: Percent of subject showing at least 2 grades of improvement based on Stanford Sleepiness Score ii)Improvement in grades based on Stanford Sleepiness Score iii)Compliance of therapy iv)Patients and physicians overall assessment for Efficacy and tolerability. Biochemical Parameters and ECG will be done baseline and after completion of therapy. Any adverse event if any will be recorded.

Detailed Description

Not available

Recruitment & Eligibility

Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1)Male, non-pregnant female and female taking suitable precautions for contraception between the ages of 18 and 60 years worked each month at least five night shifts for 12 hours or less, with 6 hours or more worked between 10 p.m. and 8 a.m. and at least three shifts occurring consecutively.2)Patients with Shift work sleep disorder diagnosed by following (The international classification of sleep disorder) criteria:A.The patient has a primary complaint of insomnia or excessive sleepiness.B.The primary complaint is temporally associated with a work period (usually night work) that occurs during the habitual sleep phase.C.No medical or mental disorder accounts for the symptoms.D.The symptoms do not meet criteria for any other sleep disorder producing insomnia or excessive sleepiness (e.g., time-zone change [jet lag] syndrome).Minimal Criteria: A plus B.3)Willing to give written informed consent & willing to comply with trial protocol.

Exclusion Criteria

1)Patients < 18 and > 60 years of age.2)Patients with significant liver/kidney/heart diseases.3)Presence of clinically significant, uncontrolled psychiatric or medical condition.4)Patients with known history of hypersensitivity to formulation.5)Patients operating an automobile or hazardous machinery.6)Pregnant and lactating mother.7)Female of reproductive age and willing to become pregnant.8)Female of reproductive age using steroidal contraceptives.9)Patients with Alcohol or drug abuse.10)Caffeine consumption averaging more than 600 mg/day within 1 week of baseline11)Use of other concomitant medications which inhibit, induce or metabolized by CYP450 viz: Carbamazepine, phenobarbital, rifampin, ketoconazole, erythromycin, cyclosporine, ethinyl estradiol, triazolam, phenytoin, diazepam, and propranolol, omeprazole and clomipramine etc.12)Patients using sedative or CNS acting drugs or medication liable to affect outcome of the study (e.g. antihistamines, selective serotonin reuptake inhibitors, tricyclic antidepressants, lithium, antipsychotics, anticonvulsants, monoamine oxidase inhibitor, benzodiazepines, psychostimulants and anticoagulants).13)Patients without the ability to comply with the study protocol and complete the study in the judgment of the investigator.

Study & Design

Study Type
Not specified
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1)Responder rate 2)Improvement in grades based on Stanford Sleepiness Score 3)Compliance of therapy 4)Patients and physicians overall assessment for Efficacy and tolerabilityBaseline, 4, 8 and 12 weeks
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (22)

A J Medical Care Pvt Ltd

🇮🇳

Pune, MAHARASHTRA, India

Abhishek Hospital

🇮🇳

Vadodara, GUJARAT, India

Dhanvantari Hospital

🇮🇳

Pune, MAHARASHTRA, India

Dr. Abhay Paliwal?s Clinic

🇮🇳

Indore, MADHYA PRADESH, India

Dr. Gurpreet Dhingra

🇮🇳

Mumbai, MAHARASHTRA, India

Dr. Hemal Mehta

🇮🇳

Mumbai, MAHARASHTRA, India

Dr. Hemang Desai

🇮🇳

Ahmadabad, GUJARAT, India

Dr. Manoj Rohra

🇮🇳

Mumbai, MAHARASHTRA, India

Dr. Sanjay Phadke

🇮🇳

Pune, MAHARASHTRA, India

Dr. Umesh Nagapurkar

🇮🇳

Nashik, MAHARASHTRA, India

Scroll for more (12 remaining)
A J Medical Care Pvt Ltd
🇮🇳Pune, MAHARASHTRA, India
Dr. Asawari A. Dhavale
Principal investigator
info@ajorganica.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.